
Dr Lal Pathlabs Shows Trend Reversal Amid Mixed Performance Indicators
2025-04-02 14:35:22Dr Lal Pathlabs experienced a notable performance on April 2, 2025, reversing a two-day decline. The stock reached an intraday high and is currently positioned above its short-term moving averages, while lagging behind longer-term averages. Year-to-date, it has faced challenges compared to the broader market.
Read More
Dr Lal Pathlabs Faces Decline Amid Broader Market Downturn and Underperformance Trends
2025-04-01 12:05:21Dr Lal Pathlabs has faced a significant decline amid a broader market downturn, underperforming its sector and experiencing consecutive losses. The stock is currently trading below key moving averages, indicating a bearish trend. Despite a yearly increase, its year-to-date performance and three-year outlook remain concerning compared to the Sensex.
Read MoreDr. Lal Pathlabs Faces Mixed Technical Trends Amidst Strong Long-Term Performance
2025-03-26 08:04:14Dr. Lal Pathlabs, a prominent player in the Hospital & Healthcare Services sector, has recently undergone an evaluation revision reflecting its current market dynamics. The stock is currently priced at 2499.15, slightly down from the previous close of 2505.70. Over the past year, the company has demonstrated a return of 17.43%, significantly outperforming the Sensex, which recorded a return of 7.12% in the same period. In terms of technical indicators, the weekly MACD and Bollinger Bands suggest a bearish sentiment, while the monthly indicators show a mildly bearish trend. The KST presents a mixed picture, with a bullish stance on a monthly basis, contrasting with the bearish weekly outlook. The Dow Theory indicates a mildly bullish trend on a weekly basis, although it shifts to mildly bearish on a monthly scale. The stock's performance over various time frames reveals a complex picture. While it has face...
Read More
Dr Lal Pathlabs Navigates Mixed Performance Amid Sector Outperformance and Market Trends
2025-03-10 11:35:23Dr Lal Pathlabs experienced significant trading activity, outperforming its sector and reaching an intraday high. The stock shows mixed performance across various moving averages and has had a strong week, despite a decline over the past month and year-to-date. It has outperformed the Sensex over the past year.
Read More
Dr Lal Pathlabs Shows Resilience Amid Mixed Market Trends and Small-Cap Gains
2025-03-06 14:05:22Dr Lal Pathlabs has experienced significant activity, marking its fourth consecutive day of gains and outperforming its sector. The stock's performance shows a mixed trend relative to various moving averages. In the broader market, the Sensex opened higher, with small-cap stocks leading the gains.
Read MoreDr. Lal Pathlabs Faces Technical Trend Shifts Amid Market Volatility and Mixed Signals
2025-03-06 08:02:37Dr. Lal Pathlabs, a prominent player in the Hospital & Healthcare Services sector, has recently undergone an evaluation revision reflecting its current market dynamics. The stock is currently priced at 2,422.15, showing a slight increase from the previous close of 2,388.70. Over the past year, the stock has reached a high of 3,645.00 and a low of 1,943.20, indicating significant volatility. The technical summary reveals a bearish sentiment in the weekly MACD and daily moving averages, while the monthly indicators show a mildly bearish trend. The Relative Strength Index (RSI) remains neutral, suggesting a lack of strong momentum in either direction. Additionally, the Bollinger Bands and KST metrics indicate mixed signals, with the KST showing bullish tendencies on a monthly basis. In terms of performance, Dr. Lal Pathlabs has experienced varied returns compared to the Sensex. Over the past week, the stock ...
Read MoreDr. Lal Pathlabs Faces Technical Trend Challenges Amid Market Volatility
2025-03-04 08:01:23Dr. Lal Pathlabs, a prominent player in the Hospital & Healthcare Services sector, has recently undergone an evaluation revision reflecting its current market dynamics. The stock is currently priced at 2,349.90, showing a slight increase from the previous close of 2,309.70. Over the past year, the stock has reached a high of 3,645.00 and a low of 1,943.20, indicating significant volatility. In terms of technical indicators, the MACD shows a bearish trend on a weekly basis while being mildly bearish on a monthly scale. The Relative Strength Index (RSI) indicates bullish momentum weekly, but no signal is present on a monthly basis. Bollinger Bands and Dow Theory both reflect a mildly bearish stance for the weekly and monthly periods. The KST presents a mixed picture, being bearish weekly but bullish monthly. When comparing the stock's performance to the Sensex, Dr. Lal Pathlabs has faced challenges, particu...
Read More
Dr Lal Pathlabs Faces Continued Stock Decline Amid Market Challenges
2025-02-25 10:35:20Dr Lal Pathlabs has faced a significant decline in stock performance, marking three consecutive days of losses and an overall drop of 4.66%. The company has underperformed compared to its sector and is trading below key moving averages, reflecting ongoing challenges in the market.
Read MoreDr Lal Pathlabs Faces Stock Volatility Amidst Challenging Market Conditions
2025-02-25 10:19:49Dr Lal Pathlabs Ltd, a prominent player in the Hospital & Healthcare Services sector, has experienced significant fluctuations in its stock performance. Currently, the stock is down 30.73% from its recent high, reflecting a challenging market environment. Over the past year, Dr Lal Pathlabs has posted a modest return of 2.36%, slightly outperforming the Sensex, which recorded a 2.12% gain. However, the stock has faced notable declines in shorter time frames, including a 3.17% drop today and an 11.32% decrease over the past month. Despite a five-year performance increase of 51.68%, the stock's year-to-date performance shows a decline of 16.25%, contrasting with the Sensex's 4.41% drop. The company's price-to-earnings ratio stands at 51.86, slightly above the industry average of 50.19, indicating a relatively high valuation. Dr Lal Pathlabs maintains a strong management efficiency with a return on equity of ...
Read MoreGrant Of Stock Options
09-Apr-2025 | Source : BSEDisclosure Attached
Announcement under Regulation 30 (LODR)-Change in Directorate
31-Mar-2025 | Source : BSEDisclosure attached
Closure of Trading Window
25-Mar-2025 | Source : BSEIntimation of Closure of Trading Window
Corporate Actions
No Upcoming Board Meetings
Dr Lal Pathlabs Ltd has declared 60% dividend, ex-date: 05 Feb 25
No Splits history available
No Bonus history available
No Rights history available